Short term follow-up of a patient with uncomplicated type B aortic dissection under dabigatran treatment
| Autor: | Fatih Aydın, Mustafa Emin Canakci, Özge Turgay Yıldırım, Ayşe Hüseyinoğlu Aydın, Ercan Akşit |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Aortic arch
Aortic valve medicine.medical_specialty lcsh:Internal medicine lcsh:Diseases of the circulatory (Cardiovascular) system lcsh:Medicine 030204 cardiovascular system & hematology Dabigatran 03 medical and health sciences Aortic aneurysm 0302 clinical medicine Aneurysm medicine.artery Ascending aorta medicine atrial fibrillation 030212 general & internal medicine lcsh:RC31-1245 Aortic dissection business.industry computerized tomography dabigatran type b aortic dissection lcsh:R medicine.disease Surgery medicine.anatomical_structure lcsh:RC666-701 Descending aorta cardiovascular system Cardiology and Cardiovascular Medicine business medicine.drug |
| Zdroj: | Türk Kardiyoloji Derneği Arşivi, Vol 47, Iss 5, Pp 413-416 (2019) |
| ISSN: | 1016-5169 |
| Popis: | This case report illustrates the follow-up of a 57-year-old female with a type B aortic dissection (AD) under dabigatran treatment. The patient had been operated on 8 years earlier due to type A AD. The aortic valve was repaired and a 26-mm polyester fiber graft was applied to the ascending aorta and the aortic arch. In computerized tomography scans taken after the procedure, a dissection flap extending from the descending aorta to the iliac arteries was seen, but the patient was asymptomatic and no further surgery was performed. The patient was subsequently diagnosed with atrial fibrillation. A CHA₂DS₂VASc score of 3 was recorded and dabigatran treatment was initiated. The aortic aneurysm and dissection were followed up via computed tomography and echocardiography at regular intervals, and at 6 months no progression was seen. No thromboembolic or hemorrhagic events were observed. To our knowledge, this is the first case report of dabigatran treatment for a patient with a type B AD. Based on this case, the use of dabigatran would appear to be safe in a patient with an uncomplicated type B AD, but the results of this case need to be confirmed with extended follow-up and additional patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|